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Dna2 is a highly conserved helicase/nuclease that in yeast participates in Okazaki fragment processing, DNA
repair, and telomere maintenance. Here, we investigated the biological function of human Dna2 (hDna2).
Immunofluorescence and biochemical fractionation studies demonstrated that hDna2 was present in both the
nucleus and the mitochondria. Analysis of mitochondrial hDna2 revealed that it colocalized with a subfraction
of DNA-containing mitochondrial nucleoids in unperturbed cells. Upon the expression of disease-associated
mutant forms of the mitochondrial Twinkle helicase which induce DNA replication pausing/stalling, hDna2
accumulated within nucleoids. RNA interference-mediated depletion of hDna2 led to a modest decrease in
mitochondrial DNA replication intermediates and inefficient repair of damaged mitochondrial DNA. Impor-
tantly, hDna2 depletion also resulted in the appearance of aneuploid cells and the formation of internuclear
chromatin bridges, indicating that nuclear hDna2 plays a role in genomic DNA stability. Together, our data
indicate that hDna2 is similar to its yeast counterpart and is a new addition to the growing list of proteins that
participate in both nuclear and mitochondrial DNA maintenance.
DNA damage arises from errors in the replication process,
as well as a myriad of intrinsic and extrinsic DNA-damaging
agents that continually assault cells. Failure to efficiently repair
DNA lesions leads to accumulation of mutations that contrib-
ute to numerous pathologies, including carcinogenesis. In ad-
dition to genomic DNA, mitochondrial DNA (mtDNA) is sub-
ject to damage that requires repair to maintain integrity. For
these reasons, it is not surprising that DNA replication and
repair proteins display significant plasticity that allows partic-
ipation in several divergent replication and repair processes. In
addition, numerous mechanisms, including alternative splicing,
posttranslational modifications, or utilization of alternative
translation initiation start sites, allow DNA replication and
repair proteins such as Pif1, DNA ligase III, and APE1 to
localize to the nucleus and the mitochondrion and participate
in DNA replication and/or repair (9, 17, 25), thus ensuring
genomic DNA and mtDNA integrity.
Dna2 is an evolutionarily conserved helicase/nuclease en-
zyme. Originally discovered in Saccharomyces cerevisiae, Dna2
orthologs are found throughout the animal kingdom, including
humans (5, 22, 28). Early studies demonstrated that Dna2
functions in concert with Flap endonuclease 1 (FEN1) to re-
move long DNA flaps that form upon lagging-strand DNA
replication (6). However, in contrast to FEN1, Dna2 is an
essential gene in yeast, suggesting that other proteins, includ-
ing FEN1, cannot compensate for its loss in DNA replication
or that it possesses functions beyond its role in Okazaki frag-
ment processing. In agreement with this, genetic and biochem-
ical studies have implicated Dna2 in DNA double-strand break
(DSB) repair, telomere regulation, and mitochondrial function
(8, 10, 15, 26, 38, 44, 45).
Analysis of Dna2 in yeast revealed that it undergoes dynamic
cell cycle localization. Dna2 localizes to telomeres during G1,
relocalizes throughout the genome in S phase, and moves back
to the telomere during late S/G2, where it participates in telo-
mere replication and telomerase-dependent telomere elonga-
tion (10). Dna2 also leaves the telomere following treatment
with bleomycin and localizes to sites of DNA DSBs (10). In
addition, dna2 mutants are sensitive to DNA damage induced
by gamma radiation and methanesulfonic acid methyl ester (7,
15). These phenotypes may be explained by recent work dem-
onstrating that Dna2 plays an important role in 5-end resec-
tion following DSBs. Indeed, upon induction of DSBs and
initiation of 5-end resection by the Mre11-Rad50-Xrs2 com-
plex, Dna2 and Sgs1 cooperate to further degrade the 5 end,
creating long 3 strands essential for homologous recombina-
tion (26, 45). Finally, while dna2 mutations are lethal in bud-
ding yeast, the dna2 pif1-m2 (nuclear PIF1) double mutations
rescue dna2 lethality but produce a petite phenotype, suggesting
that Dna2 is also involved in mtDNA maintenance (8).
Recently, the human ortholog of Dna2 was cloned and char-
acterized (23, 29). Biochemical analysis revealed that, similar
to its yeast counterpart, the human Dna2 (hDna2) protein
possesses nuclease, ATPase, and limited helicase activities (23,
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29), suggesting that it carries out analogous functions in yeast
and mammalian cells. However, hDna2’s putative role in
genomic DNA repair and replication was called into question
by a recent study suggesting that hDna2 is absent from the
nucleus and found exclusively within the mitochondria, where
it participates in mtDNA repair (44). Further in vitro biochem-
ical studies suggested that hDna2 also participates in mtDNA
replication (44). Here, we confirm that hDna2 localizes to the
mitochondria and demonstrate that hDna2 participates in
mtDNA replication and repair. However, our studies go fur-
ther by uncovering a nuclear form of hDna2 that plays an
important role in genomic stability. Indeed, we demonstrate
that depletion of hDna2 leads to the appearance of aneuploid
cells and the formation of internuclear chromatin bridges, in-
dicating that hDna2, like its yeast counterpart, is essential to
maintain nuclear DNA stability.
MATERIALS AND METHODS
Cell culture. Unless otherwise indicated, cells were incubated at 37°C in 5%
CO2. HeLa and HEK293 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Sigma, St. Louis, MO) containing 10% fetal bovine serum
(FBS) and 1% penicillin-streptomycin. Primary human BJ fibroblasts were cul-
tured in DMEM and M199 (4:1; Sigma, St. Louis, MO) containing 15% FBS and
1% penicillin-streptomycin. Stable cell lines expressing wild-type and various
inducible mutant forms of Twinkle were created as described previously (40) by
using the Flp-In T-Rex 293 host cell line (Invitrogen, Carlsbad, CA). The result-
ing cells were grown in DMEM (Sigma, St. Louis, MO) supplemented with 10%
FBS (Sigma, St. Louis, MO), 2 mM L-glutamine, 150 g/ml hygromycin, and 15
g/ml blasticidin in a 37oC incubator at 8.5% CO2. The U2OS and 143B osteo-
sarcoma cell lines were similarly maintained but in the absence of selection
antibiotics.
Virus production and infection. Virus production and infections were carried
out as described previously (32). Briefly, 293T cells were transfected by using
TransIT-LT1 (Mirus, Madison, WI). Virus was collected 48 h posttransfection,
and infections were carried out in the presence of 10 g/ml of protamine sulfate.
At 48 h postinfection, target cells were selected with 2 g/ml puromycin. The
pLKO.1 shDna2, pResQ shDna2, and pLKO.1 shSCR lentiviruses were pro-
duced by cotransfection with pCMVR8.2 and pCMV-VSV-G (8:1 ratio). The
sequence used for shDna2 was 5-CATAGCCAGTAGTATTCGATG-3, that
used for shDna2 was 5-GCAGTATCTCCTCTAGCTAGT-3, and that used
for shSCR was previously reported (32). For fractionation experiments, HEK293
and HeLa 1.2.11 cells were transfected on 10-cm plates with a mixture of three
Stealth small interfering RNA duplex oligonucleotides (DNA2HSS 141856,
141857, and 141858; Invitrogen) against hDna2, at 800 pmol each, by using
Lipofectamine 2000 according the manufacturer’s protocol. As a negative con-
trol, we used a Stealth Universal negative control (12935-200; Invitrogen). Cells
were isolated and processed for subcellular fractionation at 48 h following trans-
fection.
Immunoprecipitation and Western blot analysis. Cells were washed in phos-
phate-buffered saline (PBS), lysed in buffer H-500 (50 mM HEPES [pH 7.4], 500
mM NaCl, 10% glycerol, 1 mM dithiothreitol, 1 mM EDTA, 0.5% Nonidet P-40,
aprotinin, leupeptin, pepstatin, and phenylmethylsulfonyl fluoride), and soni-
cated (three cycles of a 30-s pulse and a 30-s cooling interval) (23). Cell extracts
were dialyzed overnight with H-100 (50 mM HEPES [pH 7.4], 100 mM NaCl,
10% glycerol, 1 mM dithiothreitol, 1 mM EDTA, 0.5% Nonidet P-40), and 1 mg
of lysate was immunoprecipitated. Cellular extracts were precleared for 2 h with
20 l of protein A beads (Amersham, Amersham, United Kingdom) and incu-
bated with 5 g of hDna2 antibody (42439; Abcam, Cambridge, MA) or immu-
noglobulin (IgG; Sigma, St. Louis, MO) overnight. Bound protein was eluted and
analyzed by 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and
Western blot analysis was carried with the hDna2 antibody (42439; Abcam,
Cambridge, MA). All protein concentrations were measured by using the Brad-
ford assay (3).
Mitochondrial and subcellular fractionations. Crude mitochondrial fractions
of all cell lines were obtained and validated as previously described (12). In brief,
cells were homogenized by hypotonic swelling and Dounce homogenization. The
homogenized sample was centrifuged at 800  g at 4°C for 5 min to pellet the
nuclear fraction. The centrifugation was repeated, and the resulting supernatant
was centrifuged at 12,000  g at 4°C for 10 min to obtain a mitochondrial pellet.
The mitochondrial pellet was again centrifuged with fresh homogenization buffer
and lysed either directly in sample buffer or with the addition of 50 mM Tris HCl
(pH 7.5), 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100 in the presence of
protease inhibitors (Roche). The crude nuclear pellet obtained from the initial
cell lysis was further purified with an Optiprep gradient and processed as previ-
ously described (12). All protein concentrations were measured by using the
Bradford assay (3).
Proteinase K protection assay. We used Proteinase K protection assays to
more precisely determine the localization of hDna2 within mitochondria. For
this purpose, HEK293 cell mitochondria were isolated as described above. Mi-
toplasts were made by permeabilizing the outer mitochondrial membrane with a
digitonin (50% high-pressure liquid chromatography pure) solution using a fixed
final ratio (ratio of micrograms of digitonin to micrograms of mitochondria 
0.4). Digitonin was made fresh prior to each experiment by dissolving 50%
high-pressure liquid chromatography pure digitonin (Sigma, St. Louis, MO) in
PBS (with protease inhibitors). The degree of permeabilization and, more par-
ticularly, lack of inner membrane permeabilization during mitoplast isolation
were verified by immunoblotting the final submitochondrial fractions with anti-
bodies against known endogenous proteins, including CoxII and TFAM. Mito-
chondria and mitoplasts were washed once with protease inhibitor-free PBS and
treated with proteinase K (100 g/ml) in the absence or presence of 0.5% Triton
X-100 for 15 min at 4°C. The reaction was terminated by the addition of 10 mM
(final concentration) phenylmethylsulfonyl fluoride (in ethanol), an equal vol-
ume of 2 sample buffer was added, and the sample was immediately placed at
95°C for heat denaturation prior to Western blot analysis. Western blot analyses
of cell and mitochondrial subfractions and proteinase K protection assays used
antibodies against hDna2 (42439; Abcam, Cambridge, MA), -actin (NB 600
533; Novus Biologicals, Littleton, CO), nucleophosmin (32-5200; Invitrogen),
and TFAM (kind gift of Rudolf Wiesner).
Immunofluorescence microscopy. HeLa, HEK293, U2OS, 143B, and BJ cells
were grown for 1 to 2 days on coverslips, and Flp-In T-Rex 293 cells were grown
on poly-L-lysine-coated coverslips. Cells were then washed in PBS and fixed in
3.7% paraformaldehyde, permeabilized in 0.5% Triton X-100, and treated with
blocking buffer (10% FBS, 2% goat serum, 0.2% Tween 20) at room tempera-
ture. Antibodies were diluted in blocking buffer and incubated with cells for 1 h
at room temperature. Cells were washed in PBS containing 0.02% Tween 20 and
mounted with 4,6-diamidino-2-phenylindole (DAPI). For transient transfection
of Twinkle expression constructs, TransIT-LT1 (Mirus, Madison, WI) was used.
Induction of expression of Twinkle variants using Flp-In T-Rex 293 cells was
done 2 days prior to immunofluorescence detection with the indicated amounts
of doxycycline. Immunofluorescence detection was carried out with a polyclonal
hDna2 antibody (42439; Abcam, Cambridge, MA) or Alexa-Fluor 488-conju-
gated bromodeoxyuridine (BrdU) monoclonal antibody (A21303; Invitrogen,
Carlsbad, CA) as the primary antibody. The secondary antibody was anti-rabbit
IgG–Alexa-Fluor 488 or 546 (Invitrogen, Carlsbad, CA). Detection of nucleoids
by immunofluorescence was otherwise done as described previously (12) using
IgM anti-DNA monoclonal antibody AC-30-10 (PROGEN, Shingle Springs,
CA), a monoclonal c-myc IgG antibody (Roche, Indianapolis, IN), or a poly-
clonal hDna2 antibody (42439; Abcam, Cambridge, MA) as the primary anti-
body. The secondary antibody was anti-mouse IgG–Alexa-Fluor 488 or 568
(Invitrogen, Carlsbad, CA, myc), anti-mouse IgM–Alexa-Fluor 488 or 568
(DNA), or anti-rabbit IgG–Alexa-Fluor 488 or 568 (hDna2). Images were ac-
quired with an LSM510 confocal microscope (Carl Zeiss, Thornwood, NY).
Images were processed with Photoshop 7.0 (Adobe, San Jose, CA). Colocaliza-
tion images were generated by using the calculator function in Photoshop CS2 on
the RGB merged color image. Similar images were also obtained with a colo-
calization plug-in in ImageJ (not shown). The specificity of the hDna2 antibody
in BJ cells was confirmed by coincubating hDna2 antibody with a specific block-
ing peptide (42548; Abcam, Cambridge, MA) at a 1:500 dilution.
Two-dimensional agarose gel electrophoresis. Mitochondrial nucleic acids
were extracted as previously described (42) from short hairpin RNA-infected
HEK293 cells. Purified mtDNA was digested with HincII and separated by
two-dimensional neutral/neutral agarose gel electrophoresis (2DNAGE) as pre-
viously described (4, 16, 40). Equal loading was verified by ethidium bromide
staining. Gels were transferred to a nucleic acid membrane and hybridized with
a 32P-labeled probe for human mtDNA (nucleotides 14983 to 15593). DNA
replication intermediates were quantitated by scanning the 2DNAGE gels and
normalizing them to the 1n spot of a shorter exposure by using the measuring
function in ImageJ. Briefly, boxes were drawn around ribonucleotide incorpora-
tion throughout the lagging strand (RITOLS) structures, X spikes, y arcs, bubble
arcs (long exposure), and 1n spots (shorter exposure). Each value was first
normalized to the 1n spot, added, and then normalized to the shSCR samples.
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An overall 20% reduction in mitochondrial replication intermediates was ob-
served upon hDna2 depletion averaging two different independent experiments.
mtDNA damage assay. Short hairpin RNA-infected HeLa cells were seeded at
106/10-mm culture plate and incubated overnight at 37°C. The next morning,
cells were washed once with PBS and treated with 2 mM H2O2 in medium at
37°C for 30 min. Cells were either immediately harvested or allowed to recover
in DMEM plus 10% FBS for 1, 2, or 24 h. Total cellular DNA was extracted with
a genomic DNA extraction kit (Qiagen, Valencia, CA).
Quantification of mtDNA damage was done by a quantitative PCR (qPCR)
that amplifies long DNA targets as previously described (33). Briefly, the fol-
lowing primers were used to amplify an 8.9-kb fragment of mtDNA: 5-TCTA
AGCCTCCTTATTCGAGCCGA-3 (sense) and 5-TTTCATCATGCGGAGA
TGTTGGA-3 (antisense). A 221-bp fragment of mtDNA was also amplified to
normalize to the copy number of the mitochondrial genome present: 5-CCCC
ACAAACCCCATTACTAAACCCA-3 (sense) and 5-TTTCATCATGCGGA
GATGTTGGA-3 (antisense). The relative PCR product was calculated by di-
viding the fluorescence value of the treated samples by that of the untreated
sample. Quantification of genomic DNA damage was done with a qPCR that
amplifies a 13.5-kb fragment of the -globin gene. The primers used to amplify
the -globin gene were 5-CGAGTAAGAGACCATTGTGGCAG-3 (sense)
and 5-GCACTGGCTTTAGGAGTTGGACT-3 (antisense). The relative PCR
product was normalized to the copy number of the mitochondrial genome.
Internuclear chromatin bridge assay. hDna2 knockdown and control U2OS
and HeLa cells were seeded into a 12-well plate at 5  104 cells per well 5 days
postinfection. Twenty-four hours later, cells were fixed and stained with DAPI.
The number of internuclear bridges was quantified in relation to the total num-
ber of nuclei. At least 1,000 nuclei were counted per well, and six wells were
counted for each sample. Images were processed with Photoshop 7.0 by using
the gray scale and invert function (Adobe, San Jose, CA).
Growth curve. hDna2 knockdown and control U2OS cells were seeded into
six-well plates at 7.5  104 per well, in triplicate, at 5 days postinfection. Cells
were lifted and counted at 24, 48, and 72 h after seeding.
Flow-activated cell sorting analysis. U2OS and HeLa cells were seeded at 1 
106 per 10-cm plate at 5 days postinfection. Twenty-four to 48 h later, cells were
lifted, stained with hypotonic propidium iodide, and subjected to fluorescence-
activated cell sorting analysis to determine DNA content as previously described
(36).
RESULTS
hDna2 localizes to the nucleus and cytoplasm. Yeast Dna2
is found at telomeres during the G1 phase of the cell cycle and
relocalizes to sites of DNA replication during S phase (10). In
addition, when cells are treated with DNA-damaging agents
such as bleomycin, Dna2 transits from telomeres to sites of
DNA damage (7, 10). This dramatic redistribution of Dna2
suggests that in yeast, Dna2 plays roles in both DNA replica-
tion and repair. To characterize the biological functions of
Dna2 in human cells, we first set out to establish whether it
displayed a similar dynamic subcellular localization. As ex-
pected, we noted the presence of hDna2 in the nuclei of a
variety of cell types (including BJ, HeLa, HEK293, U2OS, and
143B cells), albeit to various degrees (Fig. 1A). Primary human
BJ fibroblasts displayed the most robust hDna2 nuclear stain-
ing of the cell lines analyzed (Fig. 1A). In addition to the
nuclear staining, we also observed a robust punctate hDna2
pattern within the cytoplasm (Fig. 1A). To control for the
specificity of our antibody and demonstrate that the cytoplas-
mic and nuclear hDna2 signals were real, we depleted hDna2
from HeLa cells by RNA interference (RNAi). Upon deple-
tion of hDna2, both the nuclear and cytoplasmic hDna2 foci
were significantly reduced (Fig. 1B). Because we were unable
to achieve significant hDna2 knockdown in BJ fibroblasts,
which displayed the most robust nuclear hDna2 signal, we
utilized blocking peptides to demonstrate that the cytoplasmic
and nuclear hDna2 signals in BJ cells were lost, indicating that
the immunofluorescence signal was specific (see Fig. S1 in the
supplemental material). Taken together, our data indicate that
cytoplasmic and nuclear forms of hDna2 exist in the cell.
In primary BJ fibroblasts, we observed more-robust nuclear
hDna2, while analysis of HeLa cells revealed that hDna2 was
predominantly cytoplasmic. To determine whether most of the
FIG. 1. hDna2 localizes within the cytoplasm and the nucleus.
(A) Representative image of confocal immunofluorescence staining of
hDna2 in HeLa, U2OS, HEK293, and 143B cells and primary BJ
fibroblasts. hDna2 was stained with a polyclonal antibody targeting the
hDna2 C terminus (green), while nuclei were stained with DAPI
(blue). (B) Representative image of immunofluorescence staining of
hDna2 in HeLa cells infected with a short hairpin targeting hDna2
(shDna2, bottom) versus a control hairpin (shSCR, top). (C) Immu-
nofluorescence images of replicating HeLa cells stained for hDna2.
Cells were grown in the presence of BrdU for 1 h and stained for
hDna2 (red) and BrdU (green).
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hDna2 was retained in the cytoplasm during interphase and
localized to the nucleus upon entrance into S phase, we incu-
bated HeLa cells with BrdU for 1 h. As shown in Fig. 1C,
hDna2 did not relocalize to the nuclei of HeLa cells actively
undergoing DNA replication, suggesting that the limited nu-
clear fraction of hDna2 is sufficient to participate in replication
(Fig. 1A and 2B).
hDna2 localizes to the mitochondria. In yeast, Dna2 is a
nuclease/helicase enzyme that functions in the nucleus but is
also implicated in mtDNA maintenance (8). The existence of
cytoplasmic Dna2 raised the possibility that it localizes to the
mitochondria and participates in mtDNA replication and/or
repair. To determine whether hDna2 localizes to the mito-
chondria, we utilized a mitochondrion-specific dye, Mito-
Tracker. Osteosarcoma U2OS cells were utilized for these
studies because they are flat and contain large cytoplasms and
thus allow high resolution of the mitochondria. Upon immu-
nofluorescence analysis of hDna2 in U2OS cells, we observed
significant colocalization with MitoTracker (Fig. 2A), indicat-
ing that a substantial fraction of cytoplasmic hDna2 is present
in the mitochondria. Similar results were obtained in HeLa and
HEK293 cells (see Fig. 4; data not shown).
We next utilized subcellular fractionation to confirm our
immunofluorescence findings. Analysis of a crude mitochon-
drial fraction and a highly pure nuclear fraction of HEK293,
HeLa, 143B, and U2OS cells revealed the presence of a 120-
kDa species of hDna2 within the mitochondria and nucleus
(Fig. 2B and data not shown). Importantly, depletion of hDna2
in HEK293 and HeLa cells led to a reduction in both the
mitochondrial and nuclear bands, indicating that the 	120-
kDa band is hDna2 (Fig. 2B and data not shown). It is unlikely
that the nuclear form is the result of cytosolic contamination of
the nuclear fraction because we did not detect cytoplasmic
-actin in the nuclear fraction, whereas we did observe it in the
crude mitochondrial fractions (Fig. 2B) and cytosolic fractions
(data not shown). Similarly, we did not observe any apprecia-
ble mitochondrial contamination in our nuclear preparation
(see TFAM control). Together, these results support our im-
munofluorescence analysis and indicate that hDna2 localizes
to both the nucleus and the mitochondria.
hDna2’s presence in the mitochondria raised the possibility
that it plays a role in the replication and/or repair of mtDNA.
Therefore, we next sought to determine whether hDna2 colo-
calizes with mtDNA. Immunofluorescence analysis of hDna2
and mtDNA revealed that they were often in close juxtaposi-
tion and frequently showed overlap in their signals (Fig. 3A).
This result was confirmed by further coimmunofluorescence
experiments with the mitochondrial helicase Twinkle (Fig. 3B).
mtDNA is packed into nucleoprotein complexes referred to as
nucleoids, and the Twinkle helicase localizes to these struc-
tures (18, 35). Colocalization experiments with cells trans-
duced with enhanced green fluorescent protein (EGFP)-
tagged Twinkle revealed a modest degree of overlap in the
Twinkle and hDna2 signals (Fig. 3B), further demonstrating
that hDna2 localizes to nucleoids in a subset of mitochondria.
The limited colocalization of hDNA2 with mtDNA raised
the possibility that hDNA2 localizes within the mitochondria
but is excluded from the majority of nucleoids or that most of
the hDNA2 is situated in the outer membrane or intermem-
brane space of mitochondria. To distinguish between these
possibilities, we carried out a proteinase K protection assay
(Fig. 3C). These results showed that in both mitochondria and
mitoplasts (with the outer mitochondrial membrane ruptured
by digitonin treatment), a small fraction of hDna2 was pro-
tected from proteinase K degradation. However, hDna2 was
degraded in the presence of the detergent Triton X-100, illus-
trating the efficiency of the proteinase K treatment. As ex-
pected, TFAM, also a nucleoid protein, showed a pattern of
proteinase K protection similar to that of hDna2, but more of
the protein was protected. These data indicate that at least a
subfraction of hDna2 is found in the same mitochondrial com-
partment (inner membrane and/or matrix) as other nucleoid
proteins.
hDna2 associates withmtDNA in the presence of mutant Twin-
kle proteins that induce replication stalling and nucleoid aggre-
gation. Our initial immunofluorescence analysis of hDna2 sub-
cellular localization indicated that only a fraction of hDna2
colocalized with DNA-containing nucleoids. We next ques-
tioned whether DNA damage resulting from physiological
sources altered hDna2 subcellular localization. Twinkle is a
mitochondrion-specific helicase. Point mutations in Twinkle
have been identified in patients with progressive external oph-
thalmoplegia, a mitochondrial disorder associated with accu-
mulation of mtDNA deletions (35, 43). Importantly, expres-
FIG. 2. hDna2 localizes to the mitochondria and nucleus. (A) Con-
focal immunofluorescence images of U2OS cells showing hDna2
(green) and mitochondria (red) labeled with MitoTracker. Note the
punctate nuclear staining of hDna2. (B) Subcellular fractionation of
HEK293 cells following transduction with synthetic RNAs targeting
hDna2 mRNA. Mitochondrial (MITO) and nuclear (NUC) fractions
were resolved by 7.5% sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis and probed with the hDna2 antibody. Controls (Ctrl) for
the mitochondrial and nuclear fractions were TFAM and nucleophos-
min, respectively. The arrow indicates hDna2, and the asterisks denote
nonspecific bands. IB, immunoblot. The values on the left are molec-
ular sizes in kilodaltons.
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sion of mutant Twinkle proteins results in stalling of mtDNA
replication forks and loss of mtDNA (19, 40). To address how
hDna2 responds to mutant Twinkle protein expression, we
utilized inducible HEK293 cell lines expressing either wild-
type or mutant Twinkle protein. Importantly, the inducible cell
lines allowed us to examine the impact of acute protein ex-
pression at nearly physiological levels of Twinkle that have
been shown to be sufficient to induce stalled replication forks
within mtDNA (19, 40). Induction of wild-type Twinkle expres-
sion had little to no detectable impact on hDna2 localization
(Fig. 4). In contrast, expression of mutant Twinkle proteins
had variable effects on hDna2 localization. The G575D muta-
tion failed to alter hDna2’s subcellular localization (data not
shown), while both K421A (not shown) and K319E had only a
modest effect, producing some nucleoid aggregation and accu-
mulation of hDna2 in a subset of nucleoids. In contrast, ex-
pression of R374Q and W474C mutant proteins resulted in a
dramatic relocalization of hDna2 to mtDNA nucleoids, indi-
cating that, under some conditions, hDna2 is more perma-
nently associated with nucleoids and illustrating that its partial
colocalization under normal conditions is not by chance. This
altered hDna2 localization is exemplified by the W474C mu-
tant protein, which showed a faint uniform mitochondrial
staining, illustrating that the W474C mutant protein did not
result in a collapse or fractionation of the mitochondrial net-
work that might otherwise also explain the hDna2 accumula-
tion with W474C mutant protein-containing nucleoids.
hDna2 depletion abrogates mtDNA repair. Expression of
mutant Twinkle proteins known to cause mitochondrial repli-
cation fork stalling led to a more pronounced hDna2 nucleoid
FIG. 3. hDna2 colocalizes with mtDNA. (A) Confocal images
showing colocalization of hDna2 (green, left) with mtDNA (red) in
U2OS cells. mtDNA was stained with a specific DNA antibody
(
DNA). Colocalization is shown in black and white (right). (B) Rep-
resentative confocal images of U2OS cells transiently transfected with
Twinkle-EGFP (green, left) and stained for hDna2 (red). The right
part of the panel shows colocalization depicted in black and white.
(C) Western blot analysis of hDna2 following mitochondrial subfrac-
tionation and proteinase K treatment reveals the presence of hDna2
species within the mitochondria. HEK293 mitochondria were isolated
and subfractionated as described in Materials and Methods. Samples
were analyzed by immunoblot (IB) analysis with an antibody against
hDna2 and reprobed with an antibody against the mitochondrial nu-
cleoid protein TFAM. Approximately 20 g of mitochondrial extract
(mt), typically 3 to 5% of the starting material, was loaded. Mitoplasts
(mtpl) were loaded at an equivalent portion of the total volume.
Mitochondria (mt) and mitoplasts were left untreated, treated with 100
g/ml proteinase K (ProtK) for 15 min at 4°C, or treated with ProtK
and Triton X-100 (TXProtK), as indicated.
FIG. 4. Colocalization of hDna2 with wild-type and mutant Twin-
kle proteins. Expression of wild-type Twinkle with a myc epitope tag
and R374Q, W474C, and K319E mutant Twinkle proteins with a sim-
ilar tag was induced in Flp-In T-Rex 293 cells for 2 or 3 days with 3
ng/ml doxycycline. Twinkle proteins were detected by immunofluores-
cence assay with a myc monoclonal antibody (red), while hDna2 was
detected with a rabbit polyclonal antibody (green). Merged images (far
right) include the signal detected from staining with DAPI.
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localization. This observation raised the possibility that hDna2
contributes to mitochondrial replication and/or repair. To ad-
dress the role hDna2 plays in mitochondrial function, we uti-
lized virus-mediated RNAi to target hDna2. Introduction of an
hDna2 viral RNAi construct into HeLa cells resulted in an
	80% reduction in mRNA and protein levels (Fig. 5A and B).
To determine whether hDna2 has an impact on mtDNA re-
pair, we analyzed the kinetics of mtDNA repair upon hDna2
depletion. Cells were treated with 2 mM hydrogen peroxide
(H2O2) for 30 min to induce oxidative DNA lesions. Because
base lesions, abasic sites, and strand breaks interfere with am-
plification of DNA, long-range PCR can be used to measure
the kinetics of mtDNA repair (33). Therefore, to assess
mtDNA repair, DNA from cells expressing a control RNAi
hairpin or cells expressing a hairpin targeting hDna2 was iso-
lated following H2O2 treatment. Lesions in mtDNA were as-
sessed by PCR amplification of an 8.9-kb fragment of mtDNA
and normalized to mtDNA copy number by using a shorter
mtDNA PCR product (221 bp). As an additional control, a
DNA fragment from the nuclear -globin gene (13.5 kb) was
also amplified.
Analysis of mtDNA 0, 1, 2, and 24 h after H2O2 treatment
revealed that hDna2 depletion resulted in a significant reduc-
tion in the repair of oxidative lesions within the mtDNA (Fig.
5C). In contrast, analysis of the nuclear -globin gene revealed
no significant differences in the repair of nuclear DNA (Fig.
5D). However, given that we observed less DNA damage and
faster DNA repair kinetics within the nucleus (by 1 h, all of the
nuclear -globin is repaired; compare mtDNA and -globin
for the shSCR sample), this assay does not rule out a role for
hDna2 in nuclear DNA repair. Together, these experiments
indicate that hDna2 plays an active role in the repair of
mtDNA.
hDna2 depletion affects the fidelity of mtDNA replication. In
order to determine whether hDna2 participates in mtDNA
replication, we utilized 2DNAGE to analyze mitochondrial
replication intermediates in cells depleted of hDna2. mtDNA
was purified from HEK293 cells and digested with HincII to
release a 3.9-kb DNA fragment. Digested mtDNA was run in
two dimensions and hybridized with a mitochondrion-specific
cytochrome b probe (Fig. 6A). As shown in Fig. 6B (right side),
depletion of hDna2 led to a moderate yet reproducible de-
crease in replication intermediates. Indeed, we found a 20%
reduction in y arcs, bubble arcs, and RITOLS structures in cells
depleted of hDna2 (Fig. 6B, right side) compared to those in
control cells (shSCR) (Fig. 6B, left side). This observation
indicates that hDna2 depletion leads to reduced mtDNA rep-
lication, indicating that hDna2 participates in the replication of
mtDNA.
hDna2 is important to maintain nuclear DNA stability. Our
original subcellular fractionation and immunofluorescence
studies indicated that hDna2 was present in the mitochondria
and nucleus. This raised the possibility that hDna2, like its
yeast counterpart, is important to maintain both mitochondrial
and nuclear DNA stability (8, 10, 15, 26, 38, 45). We next
sought to determine if hDna2 participates in genomic DNA
maintenance. To address this possibility, we depleted hDna2
from several cell lines and obtained various degrees of knock-
down of hDna2 mRNA (	95% knockdown in U2OS cells,
80% in HeLa, 65% in HEK293 cells, and 20% in BJ cells).
Given the significant knockdown obtained in U2OS and HeLa
cells, we analyzed the impact of hDna2 depletion in these cells.
Upon hDna2 depletion, U2OS cells showed a dramatic growth
FIG. 5. hDna2 depletion abrogates mtDNA repair. (A) Stable
knockdown of hDna2 by virus-based RNAi determined by quantitative
reverse transcription-PCR in HeLa cells. Results are normalized to
those obtained with the shSCR control cell line. (B) Immunoblot (IB)
analysis of hDna2 immunoprecipitation (IP) from HeLa cells stably
expressing an shSCR (control) or shDna2 hairpin. (C) Histogram
representing mtDNA amplification by qPCR of DNA extracted from
HeLa cells expressing shSCR or shDna2. Cells were treated with 2 mM
H2O2 and allowed to recover for 0, 1, 2, or 24 h. An 8.9-kb mitochon-
drial PCR product was quantified by PicoGreen and normalized to
untreated samples and to the mtDNA copy number determined by the
amplification of a 221-bp short mitochondrial fragment. Error bars
represent standard errors of PCRs run in quadruplicate for each con-
dition. *, P  0.05. (D) Histogram representing the amplification of a
13.5-kb region of the -globin gene representing repair of genomic
DNA in untreated cells or 0, 1, or 24 h following H2O2 treatment.
FIG. 6. hDna2 depletion affects the fidelity of mtDNA replication.
2DNAGE analysis of purified mtDNA digested with HincII and
probed with a cytochrome b-specific fragment. (A) Schematic of
2DNAGE. The abbreviation 1n stands for a 3.9-kb nonreplicating
HincII fragment, y and y indicate the ascending and descending parts
of the y arc, and dy indicates double-Y structures. These will eventually
form resolution intermediates resembling Holliday junctions (HJL,
Holliday junction-like molecules). (B) 2DNAGE of mtDNA isolated
from control cells (left) or cells depleted of hDna2 (65% knockdown of
hDna2 mRNA; right). Numbers on the two-dimensional gels: 1,
RITOLS; 2, HJL; 3, y; 4, bubble arc.
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defect compared to control cells (Fig. 7B). Analysis of DNA
content revealed that depletion of hDna2 resulted in an accu-
mulation of cells in the G2/M phase of the cell cycle and the
appearance of aneuploid cells (Fig. 7C). Furthermore, hDna2-
depleted cells displayed a significant increase in the appear-
ance of internuclear chromatin bridges (Fig. 7D), indicative of
genomic instability. Similar results were obtained with a sec-
ond independent hDna2 construct (shDNA2), indicating that
neither phenotype was due to an RNAi off-target effect (Fig.
7A to D). In addition, hDna2 depletion in HeLa cells led to
similar results, albeit to a lesser extent, consistent with the
reduced hDna2 depletion observed in these cells (Fig. 7E).
Together, these observations demonstrate that hDna2 plays a
role in nuclear DNA stability.
DISCUSSION
In this study, we present immunofluorescence and biochem-
ical evidence for the existence of both nuclear and mitochon-
drial forms of hDna2. RNAi-directed depletion of hDna2 leads
to growth defects, accumulation of aneuploid cells, and the
appearance of internuclear chromatin bridges at high fre-
FIG. 7. Depletion of hDna2 leads to nuclear DNA instability. (A) Stable knockdown of hDna2 determined by quantitative reverse transcrip-
tion-PCR in U2OS cells. Results obtained with two independent hairpins (shDna2 and shDna2) are normalized to those obtained with the shSCR
control cell line. (B) Control U2OS cells or cells depleted of hDna2 were seeded into the wells of a six-well plate at 7.5  104 per well in triplicate.
Cells were lifted and counted 24, 48, and 72 h after seeding. Error bars represent standard errors of triplicate wells. (C) Fluorescence-activated
cytometric analysis of the cell cycle of U2OS cells expressing shDna2, shDna2, and shSCR. y axis, cell count; x axis, DNA content. (D) Relative
internuclear chromatin bridge (ICB) levels and representative bridges (arrows) following hDna2 depletion in U2OS cells. Results were normalized
to those obtained with shSCR. Note that hDna2 depletion was higher in shDna2-transduced cells than in shDna2-transduced cells. Error bars
represent standard errors, and asterisks denote P  0.05. (E) Relative internuclear chromatin bridge levels and representation of HeLa cells
following hDna2 depletion. Arrows indicate chromatin bridges. Note that hDna2 depletion in HeLa cells was lower than in U2OS cells.
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quency, demonstrating a role for hDna2 in genome stability.
Moreover, we demonstrate that hDna2 localizes within the
mitochondria, where a fraction associates with the mitochon-
drial inner membrane/matrix. In addition, hDna2 partially co-
localizes with the mitochondrion-specific helicase Twinkle,
which plays an important role in mtDNA replication. Upon the
expression of mutant Twinkle proteins known to cause repli-
cation fork stalling and DNA damage, hDna2 accumulates
within mtDNA-containing foci, indicating that hDna2 colocal-
ization with mtDNA occurs not by chance but in a temporal/
transient fashion to participate in mtDNA replication and/or
repair. In support of this, we show that depletion of hDna2
leads to reduced mtDNA repair and replication. Together,
these results indicate that hDna2 participates in DNA repair,
likely via long patch excision repair and/or homologous recom-
bination (1, 11, 14, 27, 37) and DNA replication within mito-
chondria.
Our finding that hDna2 participates in mtDNA stability is in
agreement with a recent report showing that hDna2 is a mito-
chondrial repair and replication protein (44). However, our
findings differ significantly from this report, which failed to
identify nuclear hDna2 and thus suggested that hDna2 differs
from its yeast counterpart in regard to a role in nuclear DNA
stability. Instead, our findings are in agreement with results
obtained with yeast which indicate that Dna2 plays an impor-
tant role in genomic DNA and mtDNA stability. Indeed, Budd
et al. demonstrated that while a pif1-m2 mutant grows nor-
mally on glycerol, a dna2 pif1-m2 double mutant displays a
petite phenotype indicative of mitochondrial dysfunction (8).
Furthermore, yeast Dna2 mutants exhibit defects in telomere
stability and DNA repair (10, 38). Again, our studies are in
agreement with those done with yeast by showing that hDna2
localizes to the nucleus and that hDna2 depletion results in
nuclear DNA instability. While we cannot explain the discor-
dance between the studies with regard to nuclear hDna2, it is
important to note that the amount of hDna2 detected by im-
munofluorescence inside the nucleus fluctuates from cell line
to cell line. In addition, the antibodies used in the two studies
differ, which may explain the varied localization results.
Our basic understanding of the replication and repair mech-
anisms that act on mtDNA is rudimentary, but a multitude of
proteins localize to the mitochondria and participate in DNA
replication and repair. For example, the mitochondrion-spe-
cific polymerase  and helicase Twinkle are important in
mtDNA replication and when reconstituted in vitro together
with the mitochondrial single-stranded DNA-binding protein
function as a minimal mtDNA replisome (24). The importance
of Twinkle has been underscored by the discovery of human
mutations that lead to mitochondrial diseases, including pro-
gressive external ophthalmoplegia (35), mtDNA depletion syn-
drome (21, 34), and infantile-onset spinocerebellar ataxia (20,
30). In this report, we provide in vivo evidence that hDna2
accumulates within nucleoid structures upon the expression of
mutant Twinkle proteins known to induce mtDNA stalling/
pausing. Furthermore, we demonstrate that hDna2 is impor-
tant to ensure efficient mtDNA replication. These observations
corroborate results from Zheng et al. which demonstrate that
hDna2 directly interacts with polymerase  and stimulates its
polymerase activity in vitro (44). The reduction in mitochon-
drial replication intermediates in hDna2-depleted cells could
indicate that hDna2 is important for initiating mtDNA repli-
cation and that the hDna2 helicase activity plays an essential
role in this process. Elucidating which hDna2 activity (helicase
and/or nuclease) is necessary for efficient mtDNA replication
will provide a better understanding of the molecular mecha-
nisms that govern mtDNA replication.
While the Twinkle and polymerase  proteins localize exclu-
sively to the mitochondria, other proteins with known nuclear
functions have also been found within the mitochondria. For
example, FEN1, ligase III, and the helicase Pif1 function within
the nucleus and mitochondria (17, 25, 27, 31). Investigation of the
mechanisms that control the subcellular localization of these pro-
teins revealed that the Pif1 mRNA undergoes differential splicing,
producing nuclear and mitochondrial isoforms (17), while ligase
III utilizes an alternative start site to produce a protein with and
without a mitochondrial targeting signal (25). Studies by Zheng et
al. suggested that the hDna2 mitochondrial localization signal is
present in the C terminus of the protein and that no canonical
nuclear localization signal is present (44). Therefore, we do not
know how hDna2 is alternatively targeted to the mitochondria
and the nucleus. Although in our biochemical fractionations both
hDna2 species correspond to an approximately 120-kDa protein,
we cannot assume that the mitochondrial and nuclear variants are
identical gene products. The observation that the consensus
EGFP-tagged full-length hDna2 protein seems to be exclusively
mitochondrion targeted (44) does not rule out the presence of a
distinct but similar-sized isoform that would show robust nuclear
targeting. It does, however, strengthen the notion that hDna2 is a
bona fide mitochondrial protein. Nevertheless, careful biochem-
ical fractionation with appropriate controls in our experiments
clearly demonstrated the existence of an endogenous nuclear
hDna2 protein, and RNAi-mediated knockdown resulted in a
clear nuclear phenotype, leaving no doubt that hDna2 is present
in both the mitochondrial and nuclear compartments.
Importantly, we now provide direct evidence that hDna2
functions analogously to its counterparts in yeast and Xenopus
cells, where it participates in the maintenance of nuclear DNA
stability. Here we demonstrate that hDna2 depletion leads to
reduced cell growth, accumulation of aneuploid cells, and an
increase in internuclear bridges. Interestingly, the appearance
of aneuploid cells is reminiscent of the “cut” phenotype ob-
served in Schizosaccharomcyes pombe mutants defective in
DNA replication and the S-phase/DNA damage checkpoint,
where cells with incompletely replicated genomes fail to re-
spond to the cell cycle checkpoint and enter a defective mito-
sis, resulting in aberrant DNA content (41). The appearance of
internuclear bridges in hDna2-depleted cells could also be
ascribed to hDna2’s putative role in DNA repair or telomere
stability. In yeast, Dna2 is important for telomere maintenance
(10, 38), and in mammalian cells, loss of proteins essential in
telomere stability, including the single-strand telomere-binding
protein Pot1, can lead to the formation of such structures (13,
39). Alternatively, the internuclear bridges that we observed
could be the result of defective DNA repair. Indeed, in yeast it
was shown that Dna2 plays an important role in 5-end resec-
tion and subsequent DNA repair (26, 45). Further work will
focus on determining whether hDna2 plays an important role
in telomere maintenance, DNA replication, and/or DNA re-
pair, like its yeast counterpart.
VOL. 29, 2009 HUMAN Dna2 FUNCTIONS IN THE MITOCHONDRIA AND NUCLEUS 4281
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on July 28, 2009 
m
cb.asm
.org
D
ow
nloaded from
 
ACKNOWLEDGMENTS
We thank B. Van Houten for the mtDNA damage protocol, Emily
Cheng for the MitoTracker reagent and helpful comments, S. Goffart
for the detailed protocol and advice on mtDNA analysis by 2DNAGE,
Elise Oster for technical assistance with the DNA damage assay, Avi
Silver for DNA preparations, and members of the Stewart and Spel-
brink laboratories for useful comments. We also thank Jason Weber
for critical reading of the manuscript.
This work was supported by the Cancer Biology Pathway, the Site-
man Cancer Center at Barnes-Jewish Hospital, and the Washington
University School of Medicine in St. Louis (J.P.D.); the Children’s
Discovery Institute (S.A.S.); Academy of Finland grants 110463 and
108380 (P.M.); USPHS GM087666 and the Ellison Foundation
(J.L.C.); Academy of Finland grants 110689 and 103213 and CoE
funding (J.N.S.); the Sigrid Juselius Foundation (J.N.S.); and the Tam-
pere University Hospital Medical Research Fund (9G072 and 9H079
to J.N.S.).
REFERENCES
1. Akbari, M., T. Visnes, H. E. Krokan, and M. Otterlei. 2008. Mitochondrial base
excision repair of uracil and AP sites takes place by single-nucleotide insertion
and long-patch DNA synthesis. DNA Repair (Amsterdam) 7:605–616.
2. Reference deleted.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye bind-
ing. Anal. Biochem. 72:248–254.
4. Brewer, B. J., and W. L. Fangman. 1987. The localization of replication
origins on ARS plasmids in S. cerevisiae. Cell 51:463–471.
5. Budd, M. E., and J. L. Campbell. 1995. A yeast gene required for DNA
replication encodes a protein with homology to DNA helicases. Proc. Natl.
Acad. Sci. USA 92:7642–7646.
6. Budd, M. E., and J. L. Campbell. 1997. A yeast replicative helicase, Dna2
helicase, interacts with yeast FEN-1 nuclease in carrying out its essential
function. Mol. Cell. Biol. 17:2136–2142.
7. Budd, M. E., and J. L. Campbell. 2000. The pattern of sensitivity of yeast
dna2 mutants to DNA damaging agents suggests a role in DSB and postrep-
lication repair pathways. Mutat. Res. 459:173–186.
8. Budd, M. E., C. C. Reis, S. Smith, K. Myung, and J. L. Campbell. 2006.
Evidence suggesting that Pif1 helicase functions in DNA replication with the
Dna2 helicase/nuclease and DNA polymerase . Mol. Cell. Biol. 26:2490–2500.
9. Chattopadhyay, R., L. Wiederhold, B. Szczesny, I. Boldogh, T. K. Hazra, T.
Izumi, and S. Mitra. 2006. Identification and characterization of mitochon-
drial abasic (AP)-endonuclease in mammalian cells. Nucleic Acids Res.
34:2067–2076.
10. Choe, W., M. Budd, O. Imamura, L. Hoopes, and J. L. Campbell. 2002.
Dynamic localization of an Okazaki fragment processing protein suggests a
novel role in telomere replication. Mol. Cell. Biol. 22:4202–4217.
11. Coffey, G., U. Lakshmipathy, and C. Campbell. 1999. Mammalian mitochon-
drial extracts possess DNA end-binding activity. Nucleic Acids Res. 27:3348–
3354.
12. Cooper, H. M., and J. N. Spelbrink. 2008. The human SIRT3 protein
deacetylase is exclusively mitochondrial. Biochem. J. 411:279–285.
13. de Lange, T. 2005. Shelterin: the protein complex that shapes and safeguards
human telomeres. Genes Dev. 19:2100–2110.
14. de Souza-Pinto, N. C., D. M. Wilson III, T. V. Stevnsner, and V. A. Bohr.
2008. Mitochondrial DNA, base excision repair and neurodegeneration.
DNA Repair (Amsterdam) 7:1098–1109.
15. Formosa, T., and T. Nittis. 1999. Dna2 mutants reveal interactions with Dna
polymerase 
 and Ctf4, a Pol 
 accessory factor, and show that full Dna2
helicase activity is not essential for growth. Genetics 151:1459–1470.
16. Friedman, K. L., and B. J. Brewer. 1995. Analysis of replication intermedi-
ates by two-dimensional agarose gel electrophoresis. Methods Enzymol.
262:613–627.
17. Futami, K., A. Shimamoto, and Y. Furuichi. 2007. Mitochondrial and nu-
clear localization of human Pif1 helicase. Biol. Pharm. Bull. 30:1685–1692.
18. Garrido, N., L. Griparic, E. Jokitalo, J. Wartiovaara, A. M. van der Bliek,
and J. N. Spelbrink. 2003. Composition and dynamics of human mitochon-
drial nucleoids. Mol. Biol. Cell 14:1583–1596.
19. Goffart, S., H. M. Cooper, H. Tyynismaa, S. Wanrooij, A. Suomalainen, and
J. N. Spelbrink. 2009. Twinkle mutations associated with autosomal domi-
nant progressive external ophthalmoplegia lead to impaired helicase func-
tion and in vivo mtDNA replication stalling. Hum. Mol. Genet. 18:328–340.
20. Hakonen, A. H., S. Goffart, S. Marjavaara, A. Paetau, H. Cooper, K. Mattila,
M. Lampinen, A. Sajantila, T. Lonnqvist, J. N. Spelbrink, and A. Suoma-
lainen. 2008. Infantile-onset spinocerebellar ataxia and mitochondrial reces-
sive ataxia syndrome are associated with neuronal complex I defect and
mtDNA depletion. Hum. Mol. Genet. 17:3822–3835.
21. Hakonen, A. H., P. Isohanni, A. Paetau, R. Herva, A. Suomalainen, and T.
Lonnqvist. 2007. Recessive Twinkle mutations in early onset encephalopathy
with mtDNA depletion. Brain 130:3032–3040.
22. Kang, H.-Y., E. Choi, S.-H. Bae, K.-H. Lee, B.-S. Gim, H.-D. Kim, C. Park,
S. A. MacNeill, and Y.-S. Seo. 2000. Genetic analyses of Schizosaccharomyces
pombe dna2 reveal that dna2 plays an essential role in Okazaki fragment
metabolism. Genetics 155:1055–1067.
23. Kim, J. H., H. D. Kim, G. H. Ryu, D. H. Kim, J. Hurwitz, and Y. S. Seo. 2006.
Isolation of human Dna2 endonuclease and characterization of its enzymatic
properties. Nucleic Acids Res. 34:1854–1864.
24. Korhonen, J. A., M. Gaspari, and M. Falkenberg. 2003. TWINKLE has
533 DNA helicase activity and is specifically stimulated by mitochondrial
single-stranded DNA-binding protein. J. Biol. Chem. 278:48627–48632.
25. Lakshmipathy, U., and C. Campbell. 1999. The human DNA ligase III gene
encodes nuclear and mitochondrial proteins. Mol. Cell. Biol. 19:3869–3876.
26. Liao, S., T. Toczylowski, and H. Yan. 2008. Identification of the Xenopus
DNA2 protein as a major nuclease for the 533 strand-specific processing
of DNA ends. Nucleic Acids Res. 36:6091–6100.
27. Liu, P., L. Qian, J. S. Sung, N. C. de Souza-Pinto, L. Zheng, D. F. Bogen-
hagen, V. A. Bohr, D. M. Wilson III, B. Shen, and B. Demple. 2008. Removal
of oxidative DNA damage via FEN1-dependent long-patch base excision
repair in human cell mitochondria. Mol. Cell. Biol. 28:4975–4987.
28. Liu, Q., W. Choe, and J. L. Campbell. 2000. Identification of the Xenopus
laevis homolog of Saccharomyces cerevisiae DNA2 and its role in DNA
replication. J. Biol. Chem. 275:1615–1624.
29. Masuda-Sasa, T., O. Imamura, and J. L. Campbell. 2006. Biochemical
analysis of human Dna2. Nucleic Acids Res. 34:1865–1875.
30. Nikali, K., A. Suomalainen, J. Saharinen, M. Kuokkanen, J. N. Spelbrink, T.
Lonnqvist, and L. Peltonen. 2005. Infantile onset spinocerebellar ataxia is
caused by recessive mutations in mitochondrial proteins Twinkle and
Twinky. Hum. Mol. Genet. 14:2981–2990.
31. Pinter, S. F., S. D. Aubert, and V. A. Zakian. 2008. The Schizosaccharomyces
pombe Pfh1p DNA helicase is essential for the maintenance of nuclear and
mitochondrial DNA. Mol. Cell. Biol. 28:6594–6608.
32. Saharia, A., L. Guittat, S. Crocker, A. Lim, M. Steffen, S. Kulkarni, and S. A.
Stewart. 2008. Flap endonuclease 1 contributes to telomere stability. Curr.
Biol. 18:496–500.
33. Santos, J. H., J. N. Meyer, B. S. Mandavilli, and B. Van Houten. 2006.
Quantitative PCR-based measurement of nuclear and mitochondrial DNA
damage and repair in mammalian cells. Methods Mol. Biol. 314:183–199.
34. Sarzi, E., S. Goffart, V. Serre, D. Chretien, A. Slama, A. Munnich, J. N.
Spelbrink, and A. Rotig. 2007. Twinkle helicase (PEO1) gene mutation
causes mitochondrial DNA depletion. Ann. Neurol. 62:579–587.
35. Spelbrink, J. N., F. Y. Li, V. Tiranti, K. Nikali, Q. P. Yuan, M. Tariq, S.
Wanrooij, N. Garrido, G. Comi, L. Morandi, L. Santoro, A. Toscano, G. M.
Fabrizi, H. Somer, R. Croxen, D. Beeson, J. Poulton, A. Suomalainen, H. T.
Jacobs, M. Zeviani, and C. Larsson. 2001. Human mitochondrial DNA
deletions associated with mutations in the gene encoding Twinkle, a phage
T7 gene 4-like protein localized in mitochondria. Nat. Genet. 28:223–231.
36. Stewart, S. A., B. Poon, J. B. Jowett, and I. S. Chen. 1997. Human immu-
nodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.
J. Virol. 71:5579–5592.
37. Thyagarajan, B., R. A. Padua, and C. Campbell. 1996. Mammalian mito-
chondria possess homologous DNA recombination activity. J. Biol. Chem.
271:27536–27543.
38. Tomita, K., T. Kibe, H. Y. Kang, Y. S. Seo, M. Uritani, T. Ushimaru, and M.
Ueno. 2004. Fission yeast Dna2 is required for generation of the telomeric
single-strand overhang. Mol. Cell. Biol. 24:9557–9567.
39. Veldman, T., K. T. Etheridge, and C. M. Counter. 2004. Loss of hPot1
function leads to telomere instability and a cut-like phenotype. Curr. Biol.
14:2264–2270.
40. Wanrooij, S., S. Goffart, J. L. Pohjoismaki, T. Yasukawa, and J. N. Spel-
brink. 2007. Expression of catalytic mutants of the mtDNA helicase Twinkle
and polymerase POLG causes distinct replication stalling phenotypes. Nu-
cleic Acids Res. 35:3238–3251.
41. Yanagida, M. 1998. Fission yeast cut mutations revisited: control of an-
aphase. Trends Cell Biol. 8:144–149.
42. Yasukawa, T., M. Y. Yang, H. T. Jacobs, and I. J. Holt. 2005. A bidirectional
origin of replication maps to the major noncoding region of human mito-
chondrial DNA. Mol. Cell 18:651–662.
43. Zeviani, M., N. Bresolin, C. Gellera, A. Bordoni, M. Pannacci, P. Amati, M.
Moggio, S. Servidei, G. Scarlato, and S. DiDonato. 1990. Nucleus-driven
multiple large-scale deletions of the human mitochondrial genome: a new
autosomal dominant disease. Am. J. Hum. Genet. 47:904–914.
44. Zheng, L., M. Zhou, Z. Guo, H. Lu, L. Qian, H. Dai, J. Qiu, E.
Yakubovskaya, D. F. Bogenhagen, B. Demple, and B. Shen. 2008. Human
DNA2 is a mitochondrial nuclease/helicase for efficient processing of DNA
replication and repair intermediates. Mol. Cell 32:325–336.
45. Zhu, Z., W.-H. Chung, E. Y. Shim, S. E. Lee, and G. Ira. 2008. Sgs1 helicase
and two nucleases Dna2 and Exo1 resect DNA double-strand break ends.
Cell 134:981–994.
4282 DUXIN ET AL. MOL. CELL. BIOL.
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on July 28, 2009 
m
cb.asm
.org
D
ow
nloaded from
 
